The Biologics Safety Testing Market is expected to be around US$ 8 Billion by 2028 at a CAGR of 12% in the given forecast period.
With the rising burden of biological hazards, the requirement for biological safety testing is projected to majorly boost in the upcoming period. Governmental regulatory bodies have established regulations and guidelines for laboratories and manufacturing facilities to ensure minimized contamination. Likewise, biosafety levels have been set for laboratory practices, facilities and equipment coupled with biological safety cabinets. The biosafety levels range from level one to four, with a rising degree of specific controls for microbe containment. Since, with the increasing demand for biopharmaceutical firms to be cGMP-compliant, the requirement for biologics safety testing will significantly increase globally. The growth in the pharmaceutical and biotechnology industry, huge research and development and investments by key players in the life sciences industry are to propel the market growth.
The global Biologics Safety Testing market is segregated on the basis of Product & Services as Consumables, Instrument and Services. Based on Application the global Biologics Safety Testing market is segmented in Vaccine Manufacturing, Monoclonal Antibodies Manufacturing, Cellular & Gene Therapy Products Manufacturing, Blood and Blood Products Manufacturing and Other Application. Based on Test Type the global Biologics Safety Testing market is segmented in Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-cell Proteins & DNA Detection Tests and Virus Safety Test.
The global Biologics Safety Testing market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biologics Safety Testing market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Charles River Laboratories, Inc., Lonza, Thermo Fisher Scientific, Inc., Merck Kgaa, Sgs SA, Eurofins Scientific, Wuxi Apptec, Associates of Cape Cod, Inc., Biomerieux Sa, Samsung Biologics, Genscript, Sartorius Ag, Roche Diagnostics, Pacific Biolabs, Nelson Laboratories, LLC, Agilent Technologies, Inc., Maravai Lifesciences, and others are among the major players in the global Biologics Safety Testing market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Biologics Safety Testing Market has been segmented as below:
Biologics Safety Testing Market, By Product & Services
Biologics Safety Testing Market, By Application
Biologics Safety Testing Market, By Test Type
Biologics Safety Testing Market, By Region
Biologics Safety Testing Market, By Company
The report covers:
Report Scope:
The global Biologics Safety Testing market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biologics Safety Testing market share. Major industry players with significant revenue share include Charles River Laboratories, Inc., Lonza, Thermo Fisher Scientific, Inc., Merck Kgaa, Sgs SA, Eurofins Scientific, Wuxi Apptec, Associates of Cape Cod, Inc., Biomerieux Sa, Samsung Biologics, Genscript, Sartorius Ag, Roche Diagnostics, Pacific Biolabs, Nelson Laboratories, LLC, Agilent Technologies, Inc., Maravai Lifesciences, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter’s Five Force Analysis
5. Biologics Safety Testing Market, By Product & Services
5.1. Introduction
5.2. Consumables
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Instrument
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.4. Services
5.4.1. Market Overview
5.4.2. Market Size and Forecast
6. Biologics Safety Testing Market, By Application
6.1. Introduction
6.2. Vaccine Manufacturing
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Monoclonal Antibodies Manufacturing
6.3.1. Market Overview
6.3.2. Market Size and Forecast
6.4. Cellular & Gene Therapy Products Manufacturing
6.4.1. Market Overview
6.4.2. Market Size and Forecast
6.5. Blood and Blood Products Manufacturing
6.5.1. Market Overview
6.5.2. Market Size and Forecast
6.6. Other Application
6.6.1. Market Overview
6.6.2. Market Size and Forecast
7. Biologics Safety Testing Market, By Test Type
7.1. Introduction
7.2. Endotoxin Test
7.2.1. Market Overview
7.2.2. Market Size and Forecast
7.3. Sterility Test
7.3.1. Market Overview
7.3.2. Market Size and Forecast
7.4. Mycoplasma Tests
7.4.1. Market Overview
7.4.2. Market Size and Forecast
7.5. Bioburden Tests
7.5.1. Market Overview
7.5.2. Market Size and Forecast
7.6. Residual Host-cell Proteins & DNA Detection Tests
7.6.1. Market Overview
7.6.2. Market Size and Forecast
7.7. Virus Safety Test
7.7.1. Market Overview
7.7.2. Market Size and Forecast
8. Biologics Safety Testing Market, By Geography
8.1. Introduction
8.2. North America
8.2.1. North America Biologics Safety Testing, By Product & Services
8.2.2. North America Biologics Safety Testing, By Application
8.2.3. North America Biologics Safety Testing, By Test Type
8.3. Europe
8.3.1. Europe Biologics Safety Testing, By Product & Services
8.3.2. Europe Biologics Safety Testing, By Application
8.3.3. Europe Biologics Safety Testing, By Test Type
8.4. Asia-Pacific
8.4.1. Asia-Pacific Biologics Safety Testing, By Product & Services
8.4.2. Asia-Pacific Biologics Safety Testing, By Application
8.4.3. Asia-Pacific Biologics Safety Testing, By Test Type
8.5. Rest of the World
8.5.1. Rest of the World Biologics Safety Testing, By Product & Services
8.5.2. Rest of the World Biologics Safety Testing, By Application
8.5.3. Rest of the World Biologics Safety Testing, By Test Type
9. Competitive Insights
9.1. Key Insights
9.2. Company Market Share Analysis
9.3. Strategic Outlook
9.3.1. Mergers & Acquisitions
9.3.2. New Product Developments
9.3.3. Portfolio/Production Capacity Expansions
9.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5. Others
10. Company Profiles
10.1. Charles River Laboratories, Inc.
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Lonza
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Thermo Fisher Scientific, Inc.
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Merck Kgaa
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Sgs Sa
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Eurofins Scientific
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Wuxi Apptec
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. Associates of Cape Cod, Inc.
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Biomerieux Sa
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Samsung Biologics
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
10.11. Genscript
10.11.1. Company Overview
10.11.2. Product/Service Landscape
10.11.3. Financial Overview
10.11.4. Recent Developments
10.12. Sartorius Ag
10.12.1. Company Overview
10.12.2. Product/Service Landscape
10.12.3. Financial Overview
10.12.4. Recent Developments
10.13. Roche Diagnostics
10.13.1. Company Overview
10.13.2. Product/Service Landscape
10.13.3. Financial Overview
10.13.4. Recent Developments
10.14. Pacific Biolabs
10.14.1. Company Overview
10.14.2. Product/Service Landscape
10.14.3. Financial Overview
10.14.4. Recent Developments
10.15. Nelson Laboratories, LLC
10.15.1. Company Overview
10.15.2. Product/Service Landscape
10.15.3. Financial Overview
10.15.4. Recent Developments
10.16. Agilent Technologies, Inc.
10.16.1. Company Overview
10.16.2. Product/Service Landscape
10.16.3. Financial Overview
10.16.4. Recent Developments
10.17. Maravai Lifesciences
10.17.1. Company Overview
10.17.2. Product/Service Landscape
10.17.3. Financial Overview
10.17.4. Recent Developments
The Biologics Safety Testing Market has been segmented as below:
Biologics Safety Testing Market, By Product & Services
Biologics Safety Testing Market, By Application
Biologics Safety Testing Market, By Test Type
Biologics Safety Testing Market, By Region
Biologics Safety Testing Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
